These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 1845642)

  • 1. [Adverse effects of valproic acid in epileptic infants and adolescents].
    Devilat M; Blumel JE
    Rev Chil Pediatr; 1991; 62(6):362-6. PubMed ID: 1845642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Body mass index and serum lipid changes during treatment with valproic acid in children with epilepsy.
    Grosso S; Mostardini R; Piccini B; Balestri P
    Ann Pharmacother; 2009 Jan; 43(1):45-50. PubMed ID: 19066323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A direct hepatotoxic effect of valproic acid.
    Sussman NM; McLain LW
    JAMA; 1979 Sep; 242(11):1173-4. PubMed ID: 381698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of valproic acid treatment on hair and serum zinc levels and serum biotinidase activity.
    Yilmaz Y; Tasdemir HA; Paksu MS
    Eur J Paediatr Neurol; 2009 Sep; 13(5):439-43. PubMed ID: 18922714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombophilic risk factors in epileptic children treated with valproic Acid.
    Unal O; Deda G; Teber S; Ertem M; Akar N
    Pediatr Neurol; 2009 Feb; 40(2):102-6. PubMed ID: 19135623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation of the effect of long term valproic acid treatment on plasma levels of carnitine, ammonia and amino acids related to the urea cycle in pediatric epileptic patients].
    Navarro-Quesada FJ; Lluch-Fernández MD; Vaquero-Abellán M; Marchante-Serrano C; Jiménez C
    Rev Neurol; 1997 Jul; 25(143):1037-44. PubMed ID: 9280630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum carnitine, beta-hydroxybutyrate and ammonia levels during valproic acid therapy.
    Toksoy HB; Tanzer FN; Atalay A
    Turk J Pediatr; 1995; 37(1):25-9. PubMed ID: 7732605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum and liver tissue biotinidase enzyme activity in rats which were administrated to valproic acid.
    Korkmazer N; Vurucu S; Demirkaya E; Unay B; Kul M; Akin R; Gokcay E
    Brain Dev; 2006 Sep; 28(8):515-20. PubMed ID: 16682156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endocrine effects of valproic acid therapy in girls with epilepsy: a prospective study.
    Goldberg-Stern H; Yaacobi E; Phillip M; de Vries L
    Eur J Paediatr Neurol; 2014 Nov; 18(6):759-65. PubMed ID: 25139344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antiepileptic therapy with valproinic acid. Correlations of side effects and serum levels of valproinic acid].
    Fröscher W; Schulz HU; Gugler R
    Fortschr Med; 1979 Sep; 97(34):1464-6. PubMed ID: 159246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The effect of valproate monotherapy on the activities of liver enzymes in epileptic children and adolescents].
    Fichsel H
    Nervenarzt; 1982 Dec; 53(12):691-2. PubMed ID: 6130485
    [No Abstract]   [Full Text] [Related]  

  • 12. Inverse correlation of valproic acid serum concentrations and quality of life in adolescents with epilepsy.
    Jakovljevic MB; Jankovic SM; Jankovic SV; Todorovic N
    Epilepsy Res; 2008 Aug; 80(2-3):180-3. PubMed ID: 18495431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Laboratory parameters in valproate therapy].
    Schneble H
    Nervenarzt; 1982 Dec; 53(12):684-90. PubMed ID: 6818481
    [No Abstract]   [Full Text] [Related]  

  • 14. Valproic acid in the treatment of epilepsy during the pediatric age.
    Olmos-Garcia de Alba G; Valdez JM
    Clin Electroencephalogr; 1986 Jan; 17(1):14-20. PubMed ID: 3082538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lamotrigine versus valproic acid as first-line monotherapy in newly diagnosed typical absence seizures: an open-label, randomized, parallel-group study.
    Coppola G; Auricchio G; Federico R; Carotenuto M; Pascotto A
    Epilepsia; 2004 Sep; 45(9):1049-53. PubMed ID: 15329068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Valproic acid in the treatment of epilepsy with special emphasis on serum level determination (author's transl)].
    Fröscher W; Schulz HU; Gugler R
    Fortschr Neurol Psychiatr Grenzgeb; 1978 Jun; 46(6):327-41. PubMed ID: 352872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma free carnitine in epilepsy children, adolescents and young adults treated with old and new antiepileptic drugs with or without ketogenic diet.
    Coppola G; Epifanio G; Auricchio G; Federico RR; Resicato G; Pascotto A
    Brain Dev; 2006 Jul; 28(6):358-65. PubMed ID: 16376041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic drug monitoring of antiepileptic drugs.
    Shakya G; Malla S; Shakya KN; Shrestha R
    JNMA J Nepal Med Assoc; 2008; 47(171):94-7. PubMed ID: 19079370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poor applicability of estimation method for adults to calculate unbound serum concentrations of valproic acid in epileptic neonates and infants.
    Ueshima S; Aiba T; Ishikawa N; Sato T; Kawasaki H; Kurosaki Y; Ohtsuka Y; Sendo T
    J Clin Pharm Ther; 2009 Aug; 34(4):415-22. PubMed ID: 19583674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum biotinidase activity in children treated with valproic acid and carbamazepine.
    Castro-Gago M; Gómez-Lado C; Eirís-Puñal J; Díaz-Mayo I; Castiñeiras-Ramos DE
    J Child Neurol; 2010 Jan; 25(1):32-5. PubMed ID: 19458381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.